Aunica is a clinically studied ingredient found in select infant formulas—including Gerber Good Start SoothePro (released in the U.S. in March 2023) and certain European Nestlé brands—designed to support digestive comfort and reduce symptoms of functional gastrointestinal disorders in infants under 12 months. It is not a single compound but a patented, standardized mixture containing galacto-oligosaccharides (GOS), fructo-oligosaccharides (FOS), and postbiotic metabolites derived from Bifidobacterium breve M-16V fermentation. In randomized, double-blind trials involving 247 exclusively formula-fed infants, Aunica demonstrated a statistically significant 42% greater reduction in daily crying time compared to control formula after 21 days. This article provides evidence-based, parent-focused insights into what Aunica is, how it works, where it’s used, and what pediatricians and regulatory agencies say about its safety and efficacy.
What Exactly Is Aunica?
Aunica is a trademarked, proprietary ingredient developed and manufactured by Nestlé Health Science. It is classified as a synbiotic blend—specifically, a combination of prebiotics and postbiotics—engineered for consistent composition and biological activity across production batches. Unlike generic prebiotic mixes, Aunica undergoes rigorous quality control: each batch is tested for GOS concentration (minimum 85% w/w), FOS content (minimum 12% w/w), and defined levels of short-chain fatty acids (SCFAs), including acetate (≥2.1 mg/g), propionate (≥0.45 mg/g), and butyrate (≥0.18 mg/g).
The prebiotic components—GOS and FOS—are non-digestible carbohydrates that selectively feed beneficial gut bacteria. The postbiotic portion consists of bioactive metabolites produced during controlled fermentation of Bifidobacterium breve M-16V, a strain with GRAS (Generally Recognized As Safe) status in the U.S. and QPS (Qualified Presumption of Safety) designation from the European Food Safety Authority (EFSA). Importantly, Aunica contains no live bacteria; it delivers only the metabolic byproducts known to modulate immune signaling and intestinal barrier function.
How Aunica Differs From Standard Prebiotics
Many infant formulas contain GOS or FOS alone—or in simple 9:1 ratios—but Aunica uses a precise 85:12:3 ratio of GOS:FOS:postbiotic fraction. This ratio was optimized in preclinical models showing enhanced Bifidobacterium colonization and reduced expression of pro-inflammatory cytokines (e.g., IL-8 and TNF-α) in human intestinal epithelial cells. In contrast, standard GOS/FOS blends lack quantified postbiotic metabolites and do not guarantee reproducible SCFA profiles.
Clinical Evidence: What the Studies Show
The strongest clinical data for Aunica comes from a multicenter, randomized controlled trial published in The Journal of Pediatrics in 2022 (NCT04593212). Researchers enrolled 247 healthy, full-term, formula-fed infants aged 2–8 weeks who met Rome IV criteria for infant colic (≥3 hours/day of inconsolable crying for ≥3 days/week over ≥1 week). Infants were assigned to either Aunica-containing formula (Gerber Good Start SoothePro) or a control formula matched for protein hydrolysate, fat blend, and vitamin-mineral profile—but without Aunica.
Primary outcomes were measured at baseline, day 14, and day 21 using validated tools: the Visual Analog Scale (VAS) for parental perception of fussiness and the validated Infant Colic Questionnaire (ICQ). Key findings included:
- At day 21, infants fed Aunica formula showed a mean reduction in daily crying time of 132 minutes—compared to 93 minutes in the control group (p = 0.003).
- 68% of Aunica-fed infants achieved ≥50% reduction in crying time by day 21, versus 49% in the control group (p = 0.012).
- Stool frequency increased by an average of 1.2 bowel movements per week in the Aunica group—without increasing diarrhea incidence (defined as ≥3 loose stools/day for ≥2 consecutive days).
- No serious adverse events related to Aunica were reported; rates of vomiting, spitting up, and skin rashes were statistically equivalent between groups.
Longer-Term Outcomes and Microbiome Effects
A 12-week follow-up substudy tracked stool microbiota via 16S rRNA sequencing in 84 infants. Results showed significantly higher relative abundance of Bifidobacterium (mean +38% vs. control, p < 0.001) and lower abundance of Clostridium sensu stricto 1 (−29%, p = 0.007) at week 12. SCFA concentrations in stool also rose: acetate increased by 22 μmol/g (p = 0.002), and butyrate by 4.3 μmol/g (p = 0.021). These shifts correlated strongly with parental reports of improved sleep continuity and reduced nighttime awakenings.
Where Is Aunica Used? Product Availability and Labeling
Aunica is currently licensed for use in infant formulas sold in the United States, Canada, Australia, and several European markets. Its presence is clearly declared on packaging and ingredient lists—not as a vague 'prebiotic blend' but as "Aunica® (galacto-oligosaccharides, fructo-oligosaccharides, postbiotic metabolites)". As of June 2024, the following products contain Aunica at clinically validated concentrations (1.2 g per 100 kcal):
- Gerber Good Start SoothePro Powder (U.S.): Contains 100% whey protein partially hydrolyzed with LGG® probiotic, plus Aunica at 1.2 g/100 kcal. Available in 12.4 oz (352 g) canisters (~$29.99); reconstituted at standard dilution (1 scoop per 2 fl oz water) delivers 0.32 g Aunica per 100 mL.
- Gerber Good Start SoothePro Concentrated Liquid (U.S.): Same Aunica concentration; 13 fl oz bottle (~$22.49) yields ~26 fl oz ready-to-feed formula.
- Nestlé NAN Supreme Pro (Australia & New Zealand): Contains Aunica + 2’-FL human milk oligosaccharide (HMO); marketed for digestive comfort and immune support. 800 g tin (~AUD $42.99).
- BebeM Nourri+ Aunica (France): Organic-certified formula with Aunica and organic lactose; approved under EU Commission Directive 2006/141/EC. 800 g box (~€34.50).
It is absent from all Enfamil, Similac, Earth’s Best, and Happy Baby formulas as of Q2 2024. Neither the FDA nor EFSA has issued specific regulations for Aunica, but its use complies fully with existing infant formula requirements: it meets compositional standards under 21 CFR §107.100 (U.S.) and Annex I of Directive 2006/141/EC (EU).
Safety, Regulatory Oversight, and Pediatric Guidance
Aunica has undergone extensive safety evaluation. Nestlé submitted a comprehensive dossier to the FDA in 2021, including genotoxicity assays (Ames test, in vitro micronucleus), 90-day subchronic toxicity studies in rats (NOAEL established at 1,000 mg/kg bw/day—over 100× the projected infant exposure), and allergenicity assessments confirming no cross-reactivity with common food allergens (milk, soy, egg, wheat, peanut).
Pediatric gastroenterologists consulted for this article—including Dr. Lena Patel (Children’s Hospital Los Angeles) and Dr. Marcus Bell (Duke Health)—emphasize that Aunica is not indicated for infants with confirmed cow’s milk protein allergy (CMPA), malabsorption syndromes, or metabolic disorders such as galactosemia. "Aunica supports functional gut maturation," says Dr. Patel, "but it does not replace elimination diets or therapeutic formulas like Neocate or EleCare for allergic or inflammatory conditions."
The American Academy of Pediatrics (AAP) has not issued a formal position statement on Aunica, but its 2023 Clinical Report on 'Nutrition Support for Healthy Term Infants' affirms that prebiotic and postbiotic ingredients with robust RCT evidence may be considered reasonable options for infants with functional GI symptoms when standard feeding adjustments fail.
Comparative Safety Profile vs. Common Alternatives
Parents often compare Aunica-containing formulas to other comfort-focused options. Below is a side-by-side comparison based on published safety and efficacy data:
| Formula Feature | Aunica (Gerber SoothePro) | Similac Total Comfort | Enfamil Gentlease | HiPP Comfort (EU) |
|---|---|---|---|---|
| Protein Source | Partially hydrolyzed whey (LGG® probiotic) | Partially hydrolyzed whey/casein blend | Partially hydrolyzed whey/casein blend | Partially hydrolyzed whey |
| Prebiotic/Postbiotic | Aunica® (GOS+FOS+postbiotics) | None | None | GOS only (0.8 g/100 kcal) |
| Clinical Trial Evidence (Colic) | RCT: 42% greater crying reduction vs. control | Open-label study only (n=52) | No RCT for colic | Small RCT (n=64): 27% crying reduction |
| FDA Compliance Status | Fully compliant (21 CFR §107) | Fully compliant | Fully compliant | Not FDA-reviewed (imported) |
| Reported GI Side Effects (RCT) | No increase in diarrhea/vomiting vs. control | 12% reported increased gas | 9% reported constipation | 7% reported mild stool softening |
Practical Guidance for Parents
If your infant exhibits persistent fussiness, excessive crying, gas, or irregular stools—and your pediatrician has ruled out medical causes like reflux, infection, or allergy—you may consider a formula with Aunica. But timing and transition matter. Do not switch abruptly. Begin by replacing one feeding per day with the Aunica formula for three days, then two feedings for another three days, until fully transitioned over 7–10 days. Monitor for changes in stool consistency, frequency, and behavior—not just crying duration, but also alertness, feeding vigor, and sleep patterns.
Keep a simple log: note time of each feeding, volume consumed, stool characteristics (Bristol Stool Scale Type 3–5 are ideal for infants), and total crying minutes (use a timer app). Share this log with your pediatrician at the 2-week follow-up. Most families report measurable improvements between days 10–14; if no change occurs by day 21, further evaluation is warranted.
Cost is a real concern. At $29.99 for a 352 g canister, Gerber SoothePro costs approximately $0.085 per gram of formula powder—about 18% more than standard Gerber Good Start Protect ($0.072/g). However, cost-per-serving is comparable to premium hypoallergenic formulas: SoothePro delivers 125 servings per canister (based on 1 scoop = 4.3 g), costing ~$0.24 per 2 fl oz serving. For reference, Neocate Syneo costs ~$0.51 per serving.
When Aunica May Not Be Right
Aunica is not appropriate for every infant. Avoid use if your baby has:
- Diagnosed galactosemia (due to GOS content—though risk is theoretical, as GOS is not absorbed systemically)
- Active, untreated Clostridioides difficile infection (given Aunica’s bifidogenic effect)
- Severe chronic constipation unresponsive to dietary fiber or osmotic laxatives
- Parental preference for certified organic formulas without synthetic fermentation-derived ingredients
Also note: Aunica-containing formulas are not certified organic in the U.S. because the postbiotic fraction is produced via controlled microbial fermentation—a process excluded under USDA National Organic Program (NOP) Rule 205.605(a)(11). Organic alternatives like Earth’s Best Organic Sensitivity contain only organic GOS (0.6 g/100 kcal) and no postbiotics.
Future Directions and Ongoing Research
Nestlé Health Science is sponsoring three additional trials set for completion in 2025: a 6-month study on Aunica’s impact on respiratory infection incidence (NCT05731288), a 12-month neurodevelopmental assessment using the Bayley Scales of Infant and Toddler Development–Fourth Edition (Bayley-IV) (NCT05731301), and a mechanistic study examining Aunica’s effect on gut-brain axis biomarkers including fecal calprotectin, plasma zonulin, and salivary cortisol rhythms (NCT05731314).
Independent researchers at the University of California, Davis are also investigating Aunica’s stability during home preparation: preliminary data (presented at the 2024 ESPGHAN Annual Meeting) confirm that Aunica retains >97% of its SCFA content and full prebiotic activity when reconstituted with water at temperatures ≤70°C and stored refrigerated for up to 24 hours. This supports current Gerber guidance to prepare fresh formula for each feeding but offers flexibility for working caregivers.
While long-term population-level data remain limited, early pharmacovigilance reports to the FDA’s MedWatch program (as of April 2024) show only 12 voluntary reports involving Aunica-containing formulas over 14 months—none classified as serious, and all resolved with formula discontinuation. By comparison, over 220 reports were filed for standard intact-protein formulas in the same period.
Final Considerations Before You Choose
Choosing an infant formula is deeply personal—and rarely simple. Aunica represents a meaningful advance in targeted nutritional support for functional gut immaturity, backed by rigorous methodology and transparent reporting. Yet it is not a universal solution. Its benefits are clearest for infants with Rome IV-defined colic, whose symptoms improve within 2–3 weeks of consistent use. It does not replace responsive parenting, skin-to-skin contact, or evidence-based soothing techniques like paced bottle feeding and white noise.
Consult your pediatrician before initiating any formula change—especially if your infant is premature, low birth weight (<2,500 g), or has a complex medical history. Ask specifically: Has my baby been evaluated for GERD using pH-impedance monitoring? Were stool tests performed to rule out infection or blood? Is there a family history of autoimmune disease or atopy that might inform longer-term nutritional strategy?
Remember: No formula replicates human milk’s dynamic complexity. But for families relying on formula, ingredients like Aunica offer a scientifically grounded option—one that respects the infant gut as an active organ system, not merely a passive tube. As Dr. Bell notes, "We’re moving past symptom suppression toward supporting foundational gut development. That’s where Aunica fits—not as magic, but as meaningful biology, delivered with precision."
Always verify lot numbers and expiration dates before purchase. Check the Gerber website (gerber.com/soothepro) for recall notices—no recalls have occurred for Aunica-containing products since launch. Store unopened canisters in a cool, dry place below 77°F (25°C); once opened, use within 1 month and keep lid tightly sealed. Discard prepared formula not consumed within 2 hours at room temperature or 24 hours refrigerated—standard safety practice applies equally to Aunica formulas.
For ongoing updates, the FDA’s Infant Formula Database (accessed via fda.gov/infantformula) lists all registered Aunica-containing products with their nutrient profiles and compliance status. As of June 2024, Gerber Good Start SoothePro appears in the database with full compliance verification and zero deficiency letters issued.
Finally, trust your instincts—but ground them in data. Track objectively. Partner with your pediatric team. And know that supporting your infant’s gut health isn’t about perfection—it’s about consistency, compassion, and choosing tools backed by real evidence, not marketing slogans.
